NCT01580553

The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure

The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure -A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 268 (actual)
• Sponsor: Lee's Pharmaceutical Limited · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of L-carnitine injection in treatment of Chinese patients with heart failure. A prospective, multicenter, randomized, double-blind, parallel, placebo-controlled clinical study was performed. Treatment period: 7 days, follow-up: 1 month

Detailed description

The primary objective of this study is to assess the efficacy and safety of L-carnitine injection in treatment of Chinese patients with heart failure.

Conditions

• Heart Failure,

Interventions

Type	Name	Description
DRUG	Levocarnitine Injection	Levocarnitine Injection:5ml:1g
DRUG	Levocarnitine placebo	L-Carnitine injection placebo (5ml:1g)

Timeline

• Start date: 2011-01-01
• Primary completion: 2012-03-01
• Completion: 2012-03-01
• First posted: 2012-04-19
• Last updated: 2012-04-27

Locations

1 site across 1 country: China